titanocene and Disease-Models--Animal

titanocene has been researched along with Disease-Models--Animal* in 2 studies

Reviews

1 review(s) available for titanocene and Disease-Models--Animal

Article	Year
Antitumor titanium compounds and related metallocenes. Metal ions in biological systems, 2004, Volume: 42 Topics: Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Disease Models, Animal; DNA, Neoplasm; Humans; Organometallic Compounds; Ruthenium Compounds	2004

Other Studies

1 other study(ies) available for titanocene and Disease-Models--Animal

Article	Year
Titanocene difluorides with improved cytotoxic activity. Inorganic chemistry, 2010, Feb-15, Volume: 49, Issue:4 Titanocene difluorides can be obtained by halide metathesis of the respective titanocene dichlorides with trimethyltin fluoride (Me(3)SnF), giving access to a new class of cytotoxic active substances. Furthermore, an improved method for the synthesis of diaryl-substituted titanocene dichlorides is presented. Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Inhibitory Concentration 50; Kidney Neoplasms; LLC-PK1 Cells; Male; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Organometallic Compounds; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship; Swine	2010

Article

Year

Titanocene difluorides with improved cytotoxic activity.

Inorganic chemistry, 2010, Feb-15, Volume: 49, Issue:4

Titanocene difluorides can be obtained by halide metathesis of the respective titanocene dichlorides with trimethyltin fluoride (Me(3)SnF), giving access to a new class of cytotoxic active substances. Furthermore, an improved method for the synthesis of diaryl-substituted titanocene dichlorides is presented.

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Inhibitory Concentration 50; Kidney Neoplasms; LLC-PK1 Cells; Male; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Organometallic Compounds; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship; Swine

2010